CAMP-Dependent protein kinase A activity modulates topiramate potentiation of GABA A receptors

Epilepsy Research

Volumn 96, Issue 1-2, 2011, Pages 176-179

  Simeone, Timothy A ^a,c   Wilcox, Karen S ^a,b   White, H Steve ^a,b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c CREIGHTON UNIVERSITY   (United States)

Author keywords

Anticonvulsant; Epilepsy; GABAA receptor; Phosphorylation; PKA; Topiramate

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BUCLADESINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; H 29; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; TOPIRAMATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; ELECTRODE; ENZYME ACTIVITY; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; VOLTAGE CLAMP; XENOPUS LAEVIS;

ANIMALS; ANTICONVULSANTS; BIOPHYSICS; BUCLADESINE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTRIC STIMULATION; FORSKOLIN; FRUCTOSE; GAMMA-AMINOBUTYRIC ACID; HUMANS; ISOQUINOLINES; LARVA; MEMBRANE POTENTIALS; MICROINJECTIONS; OOCYTES; PATCH-CLAMP TECHNIQUES; PROTEIN KINASE INHIBITORS; PROTEIN SUBUNITS; RECEPTORS, GABA-A; SULFONAMIDES; XENOPUS;

EID: 80052855738     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2011.05.009     Document Type: Article

References (20)

1. Ängehagen M., Ben-Menachem E., Shank R., Ronnback L., Hansson E. Topiramate modulation of kainate-induced calcium currents is inversely related to channel phosphorylation level. J. Neurochem. 2004, 88:320-325.
2. Ängehagen M., Ronnback L., Hansson E., Ben-Menachem E. Topiramate reduces AMPA-induced Ca(2+) transients and inhibits GluR1 subunit phosphorylation in astrocytes from primary cultures. J. Neurochem. 2005, 94:1124-1130.
3. Bracey J.M., Kurz J.E., Low B., Churn S.B. Prolonged seizure activity leads to increased protein kinase A activation in the rat pilocarpine model of status epilepticus. Brain Res. 2009, 1283:167-176.
4. Brussaard A.B., Koksma J.J. Conditional regulation of neurosteroid sensitivity of GABAA receptors. Ann. N.Y. Acad. Sci. 2003, 1007:29-36.
5. Dai S., Hall D.D., Hell J.W. Supramolecular assemblies and localized regulation of voltage-gated ion channels. Physiol. Rev. 2009, 89:411-452.
6. Gibbs J.W., Sombati S., DeLorenzo R.J., Coulter D.A. Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons. Epilepsia 2000, 41(Suppl. 1):S10-S16.
7. Hadingham K.L., Wingrove P., Le Bourdelles B., Palmer K.J., Ragan C.I., Whiting P.J. Cloning of cDNA sequences encoding human α2 and α3 γ-aminobutyric acidA receptor subunits and characterization of the benzodiazepine pharmacology of recombinant α1-, α2, α3-, and α5-containing human γ-aminobutyric acidA receptors. Mol. Pharmacol. 1993, 43:970-975.
8. McDonald B.J., Amato A., Connolly C.N., Benke D., Moss S.J., Smart T.G. Adjacent phosphorylation sites on GABAA receptor β subunits determine regulation by cAMP dependent protein kinase. Nat. Neurosci. 1998, 1:23-28.
9. Pritchett D.B., Sontheimer H., Shivers B.D., Ymer R.S., Kettenmann H., Schofield P.R., Seeburg P.H. Importance of a novel GABAA receptor subunit for benzodia-zepine pharmacology. Nature 1989, 338:582-585.
10. Rakhade S.N., Zhou C., Aujla P.K., Fishman R., Sucher N.J., Jensen F.E. Early alterations of AMPA receptors mediate synaptic potentiation induced by neonatal seizures. J. Neurosci. 2008, 28:7979-7990.
11. Ristori C., Cammalleri M., Martini D., Pavan B., Liu Y., Casini G., Dal Monte M., Bagnoli P. Involvement of the cAMP-dependent pathway in the reduction of epileptiform bursting caused by somatostatin in the mouse hippocampus. Naunyn. Schmiedebergs Arch. Pharmacol. 2008, 378:563-577.
12. Shank R.P., Gardocki J.F., Streeter A.J., Maryanoff B.E. An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action. Epilepsia 2000, 41(Suppl. 1):S3-S9.
13. Simeone T.A., Otto J.F., Wilcox K.S., White H.S. Felbamate is a subunit specific modulator of recombinant γ-aminobutyric acid type A receptors expressed in Xenopus oocytes. Eur. J. Pharmacol. 2006, 552:31-35.
14. Simeone T.A., Otto J.F., Wilcox K.S., White H.S. Subunit selectivity of topiramate modulation of heteromeric GABAA receptor. Neuropharmacology 2006, 50:845-857.
15. Simeone T.A., Wilcox K.S., White H.S. Topiramate modulation of β(1)- and β(3)-homomeric GABA(A) receptors. Pharmacol. Res. 2011, 10.1016/j.phrs.2011.03.004.
16. Simeone T.A. Mechanisms of antiepileptic drug action. Epilepsy: Mechanisms, Models, and Translational Perspectives 2010, 123-141. CRC Press. J.M. Rho, R. Sankar, C.E. Stafstrom (Eds.).
17. Swope S.L., Moss S.J., Raymond L.A., Huganir R.L. Regulation of ligand-gated ion channels by protein phosphorylation. Adv. Second Messenger Phosphoprotein Res. 1999, 33:49-78.
18. Tehrani M.H., Barnes E.M. Reduced function of gamma-aminobutyric acidA receptors in tottering mouse brain: role of cAMP-dependent protein kinase. Epilepsy Res. 1995, 22:13-21.
19. Vázquez-López A., Sierra-Paredes G., Sierra-Marcuño G. Role of cAMP-dependent protein kinase on acute picrotoxin-induced seizures. Neurochem. Res. 2005, 30:613-618.
20. Yechikhov S., Morenkov E., Chulanova T., Godukhin O., Shchipakina T. Involvement of cAMP- and Ca(2+)/calmodulin-dependent neuronal protein phosphorylation in mechanisms underlying genetic predisposition to audiogenic seizures in rats. Epilepsy Res. 2001, 46:15-25.